中华临床医师杂志(电子版)
中華臨床醫師雜誌(電子版)
중화림상의사잡지(전자판)
CHINESE JOURNAL OF CLINICIANS(ELECTRONIC VERSION)
2013年
24期
11366-11369
,共4页
PED/PEA-15%胃肿瘤%免疫组织化学
PED/PEA-15%胃腫瘤%免疫組織化學
PED/PEA-15%위종류%면역조직화학
PED/PEA-15%Stomach neoplasms%Immunohistochemistry
目的:检测凋亡抑制蛋白PED/PEA-15在胃癌中的表达,以探讨其与胃癌发生的联系及临床意义。方法收集山西医科大学第一附属医院2012年1月至12月间行手术切除且病理证实的胃癌手术标本,应用免疫组化方法分别检测40例胃癌组织、40例相应癌旁组织及40例相应肿瘤旁正常组织中凋亡抑制蛋白 PED/PEA-15的表达情况,实验结果根据阳性细胞的百分率和染色强度进行评价,三组间样本率的比较用行×列无序列联表χ2检验(检验水准α=0.05),两组间样本率的比较用独立样本的χ2检验(检验水准α=0.0167),PED/PEA-15表达与胃癌临床病理关系分析采用四格表资料χ2检验(检验水准α=0.05)。结果凋亡抑制蛋白PED/PEA-15在胃癌组织中的阳性率为70%(28/40),在癌旁组织和正常组织中阳性率分别为25%(10/40)、13%(5/40),胃癌组织中 PED/PEA-15表达较癌旁组织、肿瘤旁正常组织显著增高(P<0.05)。PED/PEA-15的表达与肿瘤细胞分化和临床分期相关(P<0.05),与不同性别、年龄、肿瘤大小、转移无关(P均>0.05)。结论 PED/PEA-15在胃癌组织中高表达,可能在胃癌发生发展过程中起着重要的作用,可作为判断人胃癌生物学行为的参考指标,且有望成为胃癌靶向基因治疗的新靶点。
目的:檢測凋亡抑製蛋白PED/PEA-15在胃癌中的錶達,以探討其與胃癌髮生的聯繫及臨床意義。方法收集山西醫科大學第一附屬醫院2012年1月至12月間行手術切除且病理證實的胃癌手術標本,應用免疫組化方法分彆檢測40例胃癌組織、40例相應癌徬組織及40例相應腫瘤徬正常組織中凋亡抑製蛋白 PED/PEA-15的錶達情況,實驗結果根據暘性細胞的百分率和染色彊度進行評價,三組間樣本率的比較用行×列無序列聯錶χ2檢驗(檢驗水準α=0.05),兩組間樣本率的比較用獨立樣本的χ2檢驗(檢驗水準α=0.0167),PED/PEA-15錶達與胃癌臨床病理關繫分析採用四格錶資料χ2檢驗(檢驗水準α=0.05)。結果凋亡抑製蛋白PED/PEA-15在胃癌組織中的暘性率為70%(28/40),在癌徬組織和正常組織中暘性率分彆為25%(10/40)、13%(5/40),胃癌組織中 PED/PEA-15錶達較癌徬組織、腫瘤徬正常組織顯著增高(P<0.05)。PED/PEA-15的錶達與腫瘤細胞分化和臨床分期相關(P<0.05),與不同性彆、年齡、腫瘤大小、轉移無關(P均>0.05)。結論 PED/PEA-15在胃癌組織中高錶達,可能在胃癌髮生髮展過程中起著重要的作用,可作為判斷人胃癌生物學行為的參攷指標,且有望成為胃癌靶嚮基因治療的新靶點。
목적:검측조망억제단백PED/PEA-15재위암중적표체,이탐토기여위암발생적련계급림상의의。방법수집산서의과대학제일부속의원2012년1월지12월간행수술절제차병리증실적위암수술표본,응용면역조화방법분별검측40례위암조직、40례상응암방조직급40례상응종류방정상조직중조망억제단백 PED/PEA-15적표체정황,실험결과근거양성세포적백분솔화염색강도진행평개,삼조간양본솔적비교용행×렬무서렬련표χ2검험(검험수준α=0.05),량조간양본솔적비교용독립양본적χ2검험(검험수준α=0.0167),PED/PEA-15표체여위암림상병리관계분석채용사격표자료χ2검험(검험수준α=0.05)。결과조망억제단백PED/PEA-15재위암조직중적양성솔위70%(28/40),재암방조직화정상조직중양성솔분별위25%(10/40)、13%(5/40),위암조직중 PED/PEA-15표체교암방조직、종류방정상조직현저증고(P<0.05)。PED/PEA-15적표체여종류세포분화화림상분기상관(P<0.05),여불동성별、년령、종류대소、전이무관(P균>0.05)。결론 PED/PEA-15재위암조직중고표체,가능재위암발생발전과정중기착중요적작용,가작위판단인위암생물학행위적삼고지표,차유망성위위암파향기인치료적신파점。
Objective To detect the expression of inhibitor of apoptosis protein PED/PEA-15 in gastric cancer, and to investigate the relationship between ped/pea-15 and gastric cancer and its clinical significance. Methods Operation specimens of gastric cancer between January and December in 2012 were collected from the first affiliated hospital of Shan xi Medical University. All specimens had been proved by pathology. Immunohistochemical method was used to detect the expression of PED/PEA-15 in 40 cases of gastric cancer tissues, 40 cases of corresponding para carcinoma tissues and 40 cases of corresponding normal tissues adjacent to the tumor.The experimental result were evaluated according to the percentage of positive cells and the staining intensity. Row×columns unordered contingency table chi-square test was used in comparison of sample rate among three groups(test levelα=0.05).Chi-square test of independent samples was used in comparison of sample rate between the two groups(test level α=0.0167).The fourfold table chi-square test was used for analysis of relationship between expression of PED/PEA-15 and clinical pathology of gastric cancer(significance level α=0.05). Results The positive rate of the inhibitor of apoptosis protein PED/PEA-15 in gastric carcinoma, the tissue adjacent to carcinoma and normal tissues adjacent to the tumor was 70% (28/40), 25%(10/40) and 13%(5/40) respectively, The expression of PED/PEA-15 in gastric significantly increased compared with the adjacent cancer tissues and normal tissues adjacent to the tumor(P<0.05). The expression of PED/PEA-15 was associated with tumor cell differentiation and clinical stage (P<0.05), and wasn't associated with gender, age, tumor size, metastasis. (P>0.05). Conclusion The inhibitor of apoptosis protein PED/PEA-15 showed high expression in gastric carcinoma, which may play an important role in the occurrence and development of gastric carcinoma. Thus it may serve as a reference indicator for biological behaviors of gastric carcinoma and a new target for gene therapy.